FranΓ§aisπ See the interactive version (live chart) β
| Metric | Value | What it means |
|---|---|---|
| P/E (price / earnings) | 27.3 | The higher, the more growth the market expects. |
| Forward P/E | 17.9 | On next year's expected earnings. Lower than current P/E = rising earnings. |
| PEG (P/E Γ· growth) | 0.42 | Below 1 = cheap given growth; above 2 = expensive. |
| Net margin | 23% | Share of revenue that ends up as profit. |
| Revenue growth | 10% | Pace of revenue growth. |
| Price-to-book | 20.2 | Price relative to book value. |
| Market cap | $236.3 B | Total market value of the company. |
| Dividend yield | 2.71% | Annual dividend ~$9.80/share relative to price. |
| Year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2022 | $26.3 B | $6.6 B | 25% |
| 2023 | $28.2 B | $6.7 B | 24% |
| 2024 | $33.4 B | $4.1 B | 12% |
| 2025 | $36.8 B | $7.7 B | 21% |
π Open the interactive Amgen page (charts, live news) β
Amgen has a P/E of 27.3 (forward P/E 17.9) and a PEG of 0.42. A PEG below 1 is rather cheap given growth, above 2 is expensive. Verdict: rather cheap given growth.
Amgen's net margin is about 23% β the share of revenue that ends up as net profit.
Latest known revenue: $36.8 B for net income of $7.7 B. The year-by-year breakdown is in the income statement above.
Amgen (AMGN) has a market cap of about $236.3 B.
Yes: Amgen pays about $9.80/share per year, i.e. roughly a 2.71% yield at the current price.
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational information, not investment advice. Data: Yahoo Finance, recomputed by JPI Invest. A stock can be Β« cheap Β» for a bad reason.